Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.620
-0.090 (-1.91%)
May 26, 2026, 3:26 PM EDT - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $12.24 million as of May 26, 2026. Its market cap has increased by 41.96% in one year.
Market Cap
12.24M
Enterprise Value
2.34M
1-Year Change
41.96%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $12.24M, a decrease of -81.46%. That is a compound annual growth rate of -44.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 12.48M | -49.35% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 13.68M |
| Cyclerion Therapeutics | 13.44M |
| CytoMed Therapeutics | 13.37M |
| Hoth Therapeutics | 13.20M |
| Moleculin Biotech | 12.75M |
| Phio Pharmaceuticals | 12.66M |
| BioLineRx | 11.75M |
| Kairos Pharma | 11.67M |